Vilaprisan

Description: Vilaprisan (BAY 1002670) is a novel orally available and selective progesterone receptor modulator (SPRM) with antiproliferative activity against uterine fibroids (UF) and can be used for the study of uterine fibroids. Target: Progesterone Receptor. Smiles: C[C@@]12[C@]([C@]3(C([C@H](C1)C4=CC=C(S(C)(=O)=O)C=C4)=C5C(CC3)=CC(=O)CC5)[H])(CC[C@]2(C(C(F)(F)F)(F)F)O)[H]. References: Schultze-Mosgau MH,et,al. Clinical Pharmacokinetics and Pharmacodynamics of the Selective Progesterone Receptor Modulator Vilaprisan: A Comprehensive Overview. Clin Pharmacokinet. 2022 Jan,61(1):1-16.